AGO Algorithms for the Treatment of Breast Cancer: Update 2021
Standard
AGO Algorithms for the Treatment of Breast Cancer: Update 2021. / Schneeweiss, Andreas; Fasching, Peter A; Fehm, Tanja; Gerber, Bernd; Jackisch, Christian; Loibl, Sibylle; Schmidt, Marcus; Stickeler, Elmar; Wöckel, Achim; Janni, Wolfgang; Müller, Volkmar; AGO Kommission Mamma .
in: GEBURTSH FRAUENHEILK, Jahrgang 81, Nr. 10, 10.2021, S. 1101-1111.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - AGO Algorithms for the Treatment of Breast Cancer: Update 2021
AU - Schneeweiss, Andreas
AU - Fasching, Peter A
AU - Fehm, Tanja
AU - Gerber, Bernd
AU - Jackisch, Christian
AU - Loibl, Sibylle
AU - Schmidt, Marcus
AU - Stickeler, Elmar
AU - Wöckel, Achim
AU - Janni, Wolfgang
AU - Müller, Volkmar
AU - AGO Kommission Mamma
N1 - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
PY - 2021/10
Y1 - 2021/10
N2 - Therapy options shown in the algorithms are based on the current AGO recommendations, but cannot represent all evidence-based treatment options, since prior therapies, performance status, comorbidities, patient preference, etc. must be taken into account for the actual treatment choice. In individual cases, other evidence-based treatment options may also be appropriate and justified. Regardless of approval status, the algorithms only take into account drugs that were available in Germany at the time the algorithm was last updated. Here we present the 2021 update of AGO treatment algorithms for early and metastatic breast cancer, which are intended to intensify structured treatment decision by providing reproducible and evidence-based treatment paths and may be helpful for a broad treatment landscape.
AB - Therapy options shown in the algorithms are based on the current AGO recommendations, but cannot represent all evidence-based treatment options, since prior therapies, performance status, comorbidities, patient preference, etc. must be taken into account for the actual treatment choice. In individual cases, other evidence-based treatment options may also be appropriate and justified. Regardless of approval status, the algorithms only take into account drugs that were available in Germany at the time the algorithm was last updated. Here we present the 2021 update of AGO treatment algorithms for early and metastatic breast cancer, which are intended to intensify structured treatment decision by providing reproducible and evidence-based treatment paths and may be helpful for a broad treatment landscape.
U2 - 10.1055/a-1519-7089
DO - 10.1055/a-1519-7089
M3 - SCORING: Journal article
C2 - 34629489
VL - 81
SP - 1101
EP - 1111
JO - GEBURTSH FRAUENHEILK
JF - GEBURTSH FRAUENHEILK
SN - 0016-5751
IS - 10
ER -